Save on prescriptions with the Ozempic® Savings Card and find out how much your Ozempic® (semaglutide) will cost with the co-pay look-up tool. Read Important Safety Information, including Boxed Warning.

GoodRx has partnered with Novo Nordisk, the maker of Ozempic, to lower the price to $966.74 for eligible patients not using insurance. Terms and conditions apply. Additionally, Novo Nordisk currently offers a Manufacturer Coupon where commercially insured patients may pay as little as $25.00 per prescription.

Ozempic ® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine used: along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes. to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes with known heart disease.

Apr 24, 2025 · Ozempic Savings Card. The Ozempic saving card by Novo Nordisk offers a discount of $100 for a 1-month prescription, $200 for a 2-month prescription, and $300 for a 3-month prescription to those with commercial or private insurance coverage for Ozempic. You can pay as little as $25 for 1, 2, or 3-month supply.

Apr 24, 2025 · Insurance often covers one pen monthly, with copays of $25–$150 USD. Uninsured patients pay $968–$1,368 per pen in the U.S. Novo Nordisk’s savings card can lower costs for eligible patients. ... Special Considerations. ... The red label Ozempic pen contains 2 mg of semaglutide, providing four 0.5 mg doses, enough for one month at one dose ...

Apr 22, 2025 · A one-month supply of Ozempic (semaglutide) can cost over $1,000 without insurance. That adds up to around $12,000 a year. ... Novo Nordisk Ozempic Savings Card Program. ... They often offer 90-day supplies, which can be cheaper per dose. Additionally, mail-order pharmacies may have special pricing agreements with insurance plans or work ...

Learn more about Novo Nordisk's medications containing semaglutide, including OZEMPIC®, WEGOVY® and RYBELSUS®. Discover their correct FDA-approved indications and applications.

SEMAGLUTIDE (SEM a GLOO tide) treats type 2 diabetes. It works by increasing insulin levels in your body, which decreases your blood sugar (glucose). It also reduces the amount of sugar released into your blood and slows down your digestion.

Jan 30, 2025 · Novo Nordisk’s weekly GLP-1 diabetes injection semaglutide has been approved by the US regulator, a potential blockbuster that the firm hopes will allow it to regain market share from...